AU4935700A - New vaccine formulations-3 - Google Patents

New vaccine formulations-3

Info

Publication number
AU4935700A
AU4935700A AU49357/00A AU4935700A AU4935700A AU 4935700 A AU4935700 A AU 4935700A AU 49357/00 A AU49357/00 A AU 49357/00A AU 4935700 A AU4935700 A AU 4935700A AU 4935700 A AU4935700 A AU 4935700A
Authority
AU
Australia
Prior art keywords
vaccine formulations
new vaccine
new
formulations
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49357/00A
Inventor
Haj Chana
Peter Smith
Darren Stevenson
Andrew Sutton
Peter Thraves
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Onyvax Ltd
Original Assignee
Onyvax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9911824.2A external-priority patent/GB9911824D0/en
Priority claimed from GBGB9911823.4A external-priority patent/GB9911823D0/en
Priority claimed from GBGB9911825.9A external-priority patent/GB9911825D0/en
Priority claimed from GB0008029A external-priority patent/GB0008029D0/en
Priority claimed from GB0008032A external-priority patent/GB0008032D0/en
Application filed by Onyvax Ltd filed Critical Onyvax Ltd
Publication of AU4935700A publication Critical patent/AU4935700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
AU49357/00A 1999-05-21 2000-05-19 New vaccine formulations-3 Abandoned AU4935700A (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
GBGB9911824.2A GB9911824D0 (en) 1999-05-21 1999-05-21 New vaccine formulations
GBGB9911823.4A GB9911823D0 (en) 1999-05-21 1999-05-21 New vaccine formulations
GB9911823 1999-05-21
GBGB9911825.9A GB9911825D0 (en) 1999-05-21 1999-05-21 New vaccine formulations
GB9911825 1999-05-21
GB9911824 1999-05-21
GB0008032 2000-04-01
GB0008029 2000-04-01
GB0008029A GB0008029D0 (en) 2000-04-01 2000-04-01 New vaccine formulations
GB0008032A GB0008032D0 (en) 2000-04-01 2000-04-01 New prostate cell lines
PCT/GB2000/001921 WO2000071156A2 (en) 1999-05-21 2000-05-19 New vaccine formulations-3

Publications (1)

Publication Number Publication Date
AU4935700A true AU4935700A (en) 2000-12-12

Family

ID=27515936

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49357/00A Abandoned AU4935700A (en) 1999-05-21 2000-05-19 New vaccine formulations-3

Country Status (2)

Country Link
AU (1) AU4935700A (en)
WO (1) WO2000071156A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050019336A1 (en) * 2003-07-23 2005-01-27 Dalgleish Angus George Human prostate cell lines in cancer treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6338853B1 (en) * 1987-04-23 2002-01-15 Jean-Claude Bystryn Anti-cancer vaccine
JPH04501663A (en) * 1988-09-23 1992-03-26 ユニバーシティ・オブ・サザン・カリフォルニア Immunotherapy vaccine for melanoma
EP0869803B1 (en) * 1995-12-28 2003-04-16 The Johns Hopkins University School Of Medicine Allogeneic paracrine cytokine tumor vaccines
CA2245099C (en) * 1996-02-02 2007-01-09 Suzanne L. Topalian Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer
AU9794698A (en) * 1997-10-10 1999-05-03 Regents Of The University Of California, The Enhanced immunogenic cell populations prepared using h2 receptor antagonists
GB9827104D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments

Also Published As

Publication number Publication date
WO2000071156A3 (en) 2001-02-22
WO2000071156A2 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU5967600A (en) Candystraw
AU4115400A (en) Short-circuiter
AU6335000A (en) Depthimeter
AU5977700A (en) Vaccines
AU7514700A (en) Cyanopiperidines
AU2023701A (en) Sketcher
AU6440900A (en) Homogentisate-dioxygenase
AU2804600A (en) Arylaminoalkylamides
AU1600401A (en) Malaria vaccine
AU6158700A (en) Vaccine
AU2699800A (en) Organoceramics
AU6098300A (en) Follistatin-3
AU4916900A (en) Benzofuranylsulfonates
AU4561600A (en) Benzofuranylaminoalcohols
AU5811600A (en) Vaccine
AU1901801A (en) Glucofuranoses
AU1915601A (en) Periotome
AU2582200A (en) Windturbine
AU7303400A (en) Osseo-distractor
AU4435300A (en) Hula-hoop
AU7513400A (en) Hydantoin-racemase
AU5084300A (en) New vaccine formulations - 1
AU2197301A (en) Microlamp

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase